Northwest Quadrant Wealth Management, LLC Abb Vie Inc. Transaction History

Northwest Quadrant Wealth Management, LLC

$439 Million
Q4 2024

A detailed history of Northwest Quadrant Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwest Quadrant Wealth Management, LLC holds 1,878 shares of ABBV stock, worth $397,272. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,878

Previous 1,865 0.7%

Holding current value

$397,272

Previous $368,000 9.51%

% of portfolio

0.08%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$164.99 - $203.87 $2,144 - $2,650	13 Added 0.7%	1,878 $333,000
Q3 2024 Oct 04, 2024	BUY	$163.84 - $199.33 $1,802 - $2,192	11 Added 0.59%	1,865 $368,000
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $2,167 - $2,530	14 Added 0.76%	1,854 $317,000
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $1,917 - $2,185	12 Added 0.66%	1,840 $335,000
Q4 2023 Jan 09, 2024	BUY	$137.6 - $154.97 $25,043 - $28,204	182 Added 11.06%	1,828 $283,000
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $1,736 - $2,010	13 Added 0.8%	1,646 $245,000
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $1,590 - $1,978	12 Added 0.74%	1,633 $220,000
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $1,590 - $1,831	11 Added 0.68%	1,621 $258,000
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $10,096 - $12,108	-73 Reduced 4.34%	1,610 $260,000
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $7,113 - $8,158	53 Added 3.25%	1,683 $226,000
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $40,047 - $50,913	-291 Reduced 15.15%	1,630 $251,000
Q1 2022 Apr 08, 2022	SELL	$131.98 - $163.75 $16,233 - $20,141	-123 Reduced 6.02%	1,921 $311,000
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $1,289 - $1,631	12 Added 0.59%	2,044 $277,000
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $10,320 - $11,715	97 Added 5.01%	2,032 $221,000
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $1,262 - $1,406	12 Added 0.62%	1,935 $217,000
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $1,329 - $1,464	13 Added 0.68%	1,923 $208,000
Q4 2020 Jan 22, 2021	BUY	$80.49 - $108.67 $153,735 - $207,559	1,910 New	1,910 $201,000
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $187,713 - $220,313	-2,185 Closed	0 $0
Q2 2020 Jul 09, 2020	SELL	$73.37 - $98.18 $13,646 - $18,261	-186 Reduced 7.84%	2,185 $211,000
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $967 - $1,466	15 Added 0.64%	2,371 $200,000
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $169,938 - $212,629	2,356 New	2,356 $209,000
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $174,236 - $222,714	-2,652 Closed	0 $0
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $539 - $635	7 Added 0.26%	2,652 $214,000
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $5,293 - $6,528	68 Added 2.64%	2,645 $204,000
Q3 2018 Nov 16, 2018	BUY	$88.91 - $98.84 $26,850 - $29,849	302 Added 13.27%	2,577 $226,000
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $204,249 - $241,673	2,275 New	2,275 $211,000

Others Institutions Holding ABBV

# of Institutions

4,100

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $374B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Quadrant Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Quadrant Wealth Management, LLC with notifications on news.

Account

Northwest Quadrant Wealth Management, LLC Abb Vie Inc. Transaction History